Global obesity surge driving premature heart disease with peak rates now in people in their early 50s and fastest growth in South Asia, major ENDO 2026 study reports
A major study presented Monday at the Endocrine Society’s annual meeting in Chicago reported that global heart disease rates now peak in people aged 50 to 54, with the fastest increase occurring in South Asia. According to researchers, rising obesity is driving this shift by causing cardiovascular disease to affect younger populations worldwide.
The ENDO 2026 study, which analyzed data from 204 countries and territories, found that the global burden of heart disease is increasingly driven by rising obesity rates, causing cardiovascular disease (CVD) to occur at younger ages, according to researchers presenting Monday at the Endocrine Society’s annual meeting in Chicago.
The study reports that heart disease rates now peak among people aged 50 to 54, a shift from the traditional pattern where the highest rates were seen in much older adults.
South Asia emerged as the fastest-growing hotspot for obesity-linked heart disease, with age-standardized rates and trends increasing more than three times faster than global averages, the study showed. Investigators described obesity as a factor “rewriting” global heart disease trends by shifting CVD from a predominantly late-life condition to one increasingly affecting people in mid-life. The Endocrine Society characterized this trend as a significant emerging global health crisis, urging policy responses that explicitly target obesity to reduce premature cardiovascular disease.
A 2024 global assessment titled “The Silent Surge: Obesity Driving a Global Cardiovascular Crisis” estimated that more than 1 billion people worldwide currently live with obesity, nearly doubling the figure since 1990. When overweight individuals are included, nearly 2.5 billion adults are affected. The report estimates that high body mass index (BMI) contributes to approximately 1.9 million cardiovascular deaths annually. The World Heart Federation has stated that obesity is a key risk factor for cardiovascular disease and noted that obesity rates have been steadily increasing over the past three decades across nearly all regions.
Data from U.S. sources illustrate the shift toward earlier heart disease onset. The Centers for Disease Control and Prevention’s WONDER database shows that obesity-related ischemic heart disease deaths increased by about 180% between 1999 and 2020, with the highest mortality rates observed among middle-aged adults aged 55 to 64. These trends highlight the growing impact of obesity on cardiovascular health in working-age populations. Clinical research from a 12-year cohort study at Johns Hopkins University found that adults with a BMI of 35 or higher and elevated high-sensitivity troponin—a marker of subclinical heart muscle injury—were nine times more likely to develop heart failure, underscoring the cardiovascular risks faced by younger, metabolically healthy adults with obesity.
The mechanisms by which obesity drives premature heart disease include its direct promotion of hypertension, type 2 diabetes, dyslipidemia, sleep apnea, and systemic inflammation, according to a scientific statement from the American Heart Association (AHA). A large Mendelian randomization and epidemiologic study published in the European Heart Journal found that each 5 kg/m² increase in BMI raises the risk of heart failure by about 41% and coronary heart disease by 15%, providing strong evidence of a causal relationship. Furthermore, obesity itself, even without classic risk factors, is linked to myocardial injury, as elevated troponin levels in obese adults predict future heart failure, supporting the concept of obesity cardiomyopathy.
Global burden analyses indicate that from 1990 to 2023, high BMI contributed to more than a twofold increase in deaths and disability-adjusted life years (DALYs) from cardiovascular diseases, particularly ischemic heart disease, hypertensive heart disease, ischemic stroke, and intracranial hemorrhage. The “Silent Surge” report emphasized that high BMI is now responsible for an estimated 1.9 million cardiovascular deaths annually, making obesity a leading modifiable driver of global cardiovascular mortality. The World Heart Federation has highlighted that in many regions, more people now live with obesity than with underweight, underscoring obesity’s significance as a public health problem worldwide.
The shift of peak heart disease burden into the early 50s is further supported by global data showing that while ischemic heart disease deaths remain highest after age 70, DALYs from high-BMI-related cardiovascular disease peak between ages 50 and 69, indicating maximal loss of healthy life in mid-life. Analyses also reveal that the risk of premature cardiovascular mortality associated with overweight and obesity begins in early adulthood, with excess risk especially pronounced among those who develop obesity at younger ages.
South Asia’s rapid increase in obesity-linked heart disease is attributed to factors including urbanization, dietary shifts toward ultra-processed foods, and rising rates of obesity and diabetes, according to global cardiovascular policy statements. The World Heart Federation and allied organizations note that South Asian populations often experience cardiovascular disease at younger ages and at lower BMI thresholds than other populations, amplifying the impact of the current obesity surge on premature cardiovascular disease. Equity-focused interventions are urgently needed in lower- and lower-middle-income regions, including South Asia, where the cardiometabolic transition is occurring rapidly.
Policy responses recommended by international health organizations include adopting national obesity action plans aligned with the World Health Organization’s 2022 “Acceleration Plan to STOP Obesity,” which sets clear targets through 2030 and calls for robust accountability mechanisms. The American Heart Association classifies obesity as a major, independent, and modifiable risk factor for cardiovascular disease and advocates for integrated prevention and treatment strategies across the life course. Global frameworks such as the WHO Acceleration Plan to Stop Obesity, the Global Action Plan for the Prevention and Control of Noncommunicable Diseases, and the Global Strategy on Diet, Physical Activity and Health explicitly link obesity control to reducing cardiovascular disease burden. Recommended interventions include taxing sugary drinks, restricting marketing of unhealthy foods to children, improving front-of-pack nutrition labeling, and redesigning urban environments to promote physical activity.
